Deal Library / Pharma BD Deal Intelligence

Servier — Pharma Deals

The Pharma Closeout tracks 14 deals, $10.6B in disclosed deal value, 4 with a post-close Outcome Score for Servier.

Median Critic Score: 78  ·  Median Outcome Score: 82

Best outcome: Servier / Agios Pharmaceuticals (oncology) (91)  ·  Weakest outcome: Servier / Symphogen A/S (66)

All 14 deals

• Servier / Agios Pharmaceuticals (oncology) — 2020 · $2.0B · Worked — the deal delivered on its rationale.
• Servier / Shire plc (Oncology Business) — 2018 · $2.4B · Worked — the deal delivered on its rationale.
• Servier / Edgewise Therapeutics, Inc. — 2026 · $2.6B · Worked — the deal delivered on its rationale.
• Servier / Symphogen A/S — 2006 · Largely worked — most objectives met.
• Servier / kyron.bio — 2026
• Servier / Vect-Horus — 2026
• Servier / Insilico Medicine — 2026 · $888M
• Servier / IDEAYA Biosciences, Inc. — 2025 · $530M
• Servier / Kaerus Bioscience Ltd. — 2025 · $450M
• Servier / Aitia — 2024
• Servier / AmoyDx — 2024
• Servier / Klineo — 2024
• Servier / Symphogen A/S — 2020
• Servier / Pieris Pharmaceuticals, Inc. — 2017 · $1.7B

← Deal Library  ·  Interactive search  ·  How we score deals